Company Analysis
Sign in

Nyxoah SA (NYXH)

Nasdaq: NYXH · Surgical & Medical Instruments & Apparatus · filing with the SEC since 2021
Full chart Alerts Compare
Grade5.2
◀ Past 5.9● Present 4.1▶ Future 5.8
7 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Income statement, as filed

In euros (EUR), as filed; per-share figures in euros; share counts. The fiscal year ends in December.
Income statement, by fiscal year, newest first
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period endingDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019
Report filedMar 26, 2026Mar 20, 2025Mar 20, 2024Mar 22, 2023Mar 24, 2022··
Cost of revenue3,694,0001,552,0001,656,0001,150,000303,00030,000·
Gross profit6,326,0002,969,0002,692,0001,934,000549,00039,000·
Research and development42,824,00034,325,00026,651,00015,861,00012,344,0002,336,000·
Selling, general and administrative48,261,00028,461,00021,687,00018,855,00014,712,0009,386,000·
Operating income-83,485,000-58,809,000-45,102,000-32,499,000-26,242,000-11,224,000·
Finance costs11,519,0005,070,0003,729,0004,320,0002,072,000990,000·
Finance income5,928,0007,447,0004,174,0006,763,0003,675,00062,000·
Income before income taxes-89,076,000-56,432,000-44,657,000-30,056,000-24,639,000-12,152,000-8,384,000
Income tax expense1,009,0002,804,000-1,445,0001,169,0002,980,00093,000·
Net income-90,085,000-59,236,000-43,212,000-31,225,000-27,618,903-12,245,000·
Net income to shareholders-90,085,000-59,236,000-43,212,000-31,225,000-27,619,000-12,245,000·
Net income to ordinary shareholders-90,085,000-59,236,000-43,212,000-31,225,000···
Earnings per share, basic-2.364-1.809-1.545-1.209-1.161-0.677·
Earnings per share, diluted-2.364-1.809-1.545-1.209-1.161-0.677·
Weighted average shares, basic38,108,43432,743,60527,968,14225,819,16523,792,69318,097,988·
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Cost of revenue what it cost to make or buy what it soldifrs-full:CostOfSales
Gross profit revenue less the cost of what it soldifrs-full:GrossProfit
Research and development spent on inventing what it sells nextifrs-full:ResearchAndDevelopmentExpense
Selling, general and administrative the cost of selling and of running the companyifrs-full:SellingGeneralAndAdministrativeExpense
Operating income profit from running the business, before interest and taxifrs-full:ProfitLossFromOperatingActivities
Finance costs what its borrowing costifrs-full:FinanceCosts
Finance income what its cash and investments earnedifrs-full:FinanceIncome
Income before income taxes profit before taxifrs-full:ProfitLossBeforeTax
Income tax expense tax charged on the period's profitifrs-full:IncomeTaxExpenseContinuingOperations
Net income the whole group's profit, minority holders' share includedifrs-full:ProfitLoss
Net income to shareholders the profit or loss that belongs to the company's shareholdersifrs-full:ProfitLossAttributableToOwnersOfParent
Net income to ordinary shareholders what is left for common shareholdersifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity
Earnings per share, basic net income per share outstandingifrs-full:BasicEarningsLossPerShare
Earnings per share, diluted net income per share, counting every share that could be issuedifrs-full:DilutedEarningsLossPerShare
Weighted average shares, basic the average count of shares outstandingifrs-full:WeightedAverageShares
SI Assistanton NYXH · research, not advice